Related references
Note: Only part of the references are listed.Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care
Clare MacRae et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2021)
Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions
Noe Garin et al.
SCIENTIFIC REPORTS (2021)
Patterns of drug use and polypharmacy burden in chronic kidney disease patients: An experience from a secondary care hospital in United Arab Emirates
Tasneem M. Shouqair et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2021)
Medicines optimization for patients with chronic kidney disease in the outpatient setting: the role of the clinical pharmacist
Alexander Schuetze et al.
INTERNATIONAL JOURNAL OF PHARMACY PRACTICE (2021)
Adverse Drug Events in Patients with Chronic Kidney Disease Associated with Multiple Drug Interactions and Polypharmacy
Julia Sommer et al.
DRUGS & AGING (2020)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Adverse Drug Reactions in Patients with CKD
Solene M. Laville et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Prevalence of Potential Drug-Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital
Gracia Santos-Diaz et al.
PHARMACEUTICS (2020)
Impact of Adverse Drug Reactions in Patients with End Stage Renal Disease in Greece
Marios Spanakis et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
Insa M. Schmidt et al.
CLINICAL KIDNEY JOURNAL (2019)
Intensive Monitoring of Adverse Drug Reactions in Nephrology Unit of Tertiary Care Teaching Hospital
Shoukath Ali Kareem et al.
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2019)
Drug-Related Problems and Associated Factors among Patients Admitted with Chronic Kidney Disease at Jimma University Medical Center, Jimma Zone, Jimma, Southwest Ethiopia: A Hospital-Based Prospective Observational Study
Aster Wakjira Garedow et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2019)
Chronic kidney disease in patients at high risk of cardiovascular disease in the United Arab Emirates: A population-based study
S. Al-Shamsi et al.
PLOS ONE (2018)
Survivability of hospitalized chronic kidney disease (CKD) patients with moderate to severe estimated glomerular filtration rate (eGFR) after experiencing adverse drug reactions (ADRs) in a public healthcare center: a retrospective 3 year study
Monica Danial et al.
BMC PHARMACOLOGY & TOXICOLOGY (2018)
Evaluation of potential drug-drug interactions among Palestinian hemodialysis patients
Rowa Al-Ramahi et al.
BMC NEPHROLOGY (2016)
Epidemiology and Referral Patterns of Patients with Chronic Kidney Disease in the Emirate of Abu Dhabi
Nick Richards et al.
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2015)
Development of an Adverse Drug Reaction Risk Assessment Score among Hospitalized Patients with Chronic Kidney Disease
Fatemeh Saheb Sharif-Askari et al.
PLOS ONE (2014)
Chapter 1: Definition and classification of CKD
Kidney International Supplements (2012)
Potentially Harmful Drug-Drug Interactions in the Elderly: A Review
Lisa E. Hines et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2011)
Share Paper
